Ex Parte VOUTE et al - Page 5


               Appeal No. 2005-0209                                                                                                  
               Application 09/274,014                                                                                                

               comprising a main monomer, a passivating monomer and a crosslinking agent, to form an                                 
               interactive polymer network that “deactivate” such innate groups and interacts with biological                        
               macromolecules (col. 5, ll. 3-39 and 50-62).  Indeed, the passivating mixture forms a three-                          
               dimensional network on the surfaces of the matrix, including the internal surfaces, that is, in the                   
               pores (e.g., col. 6, ll. 20-60, col. 10, l. 62, to col. 11, l. 21).  We find that Girot FIG. 5 illustrates            
               the network on the internal surfaces of a pore (e.g., col. 12, ll. 63-68), and one of ordinary skill in               
               the art would not have inferred from this disclosure or the disclosure at col. 19, l. 32, to col. 20, l.              
               16, which also involves the interior or internal surfaces of a pore, that the interactive polymer                     
               network is formed solely on the interior or internal surfaces of the pore.  Indeed, we find no                        
               disclosure in the reference which teaches that the innate groups of the solid mineral oxide matrix                    
               that can enter into undesirable interactions are found solely in the interior or internal pore                        
               surfaces of that matrix and not on the exterior or external surfaces thereof, such teachings being                    
               necessary to support appellants’ view of the reference.                                                               
                       Turning now to the pore volume requirement, appellants submit that Girot alone would                          
               not have suggested a pore volume of less than 30% of the total volume of the mineral oxide                            
               matrix because, as established by a declaration by Dr. Boschetti, a patentee in Girot, an applicant                   
               herein and employed by the common assignee,1 “the purpose of [Girot] was to make the pore                             
               volume as large as possible . . . [which] is consistent with calculated pore volumes of 40 to 60%                     
               for Girot” (brief, e.g., page 10).  Thus, appellants contend that Girot “relates primarily to porous                  
               silica, for which a porous volume of 0.8 to 1.2 cm3/gr equates to a pore volume of between 0.4 to                     
               0.6 ml per ml of solid material or between 40 and 60%” (brief, page 12).  Appellants contend                          
               that the “pore volume of 40 and 60% . . . is in line with” the testimony in the Boschetti                             
               declaration alleged to establishes that “the purpose of the invention in [Girot] was to have a                        
               hydrogel fill the pores entirely, while allowing even macromolecules still to diffuse inside” and                     
               thus the pore volume is “made as large as possible, to maximize the binding capacity of the final                     
               material” (id.).  On this basis, appellants submit that Girot “would not have led one of ordinary                     
               skill to decrease porosity, or pore volume below 30%” (id.).  Appellants further point to col. 19,                    
               ll. 32-55, and col. 19, l. 62, to col. 20, l. 8, of Girot as being contrary to the claimed invention                  




                                                                - 5 -                                                                



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007